4.8 Article

Engineering Single-Atomic Iron-Catalyst-Integrated 3D-Printed Bioscaffolds for Osteosarcoma Destruction with Antibacterial and Bone Defect Regeneration Bioactivity

期刊

ADVANCED MATERIALS
卷 33, 期 31, 页码 -

出版社

WILEY-V C H VERLAG GMBH
DOI: 10.1002/adma.202100150

关键词

bioscaffolds; nanocatalytic therapy; osteogenesis; osteosarcoma; single-atom catalysts

资金

  1. National Key Research and Development Program of China [2016YFA0203700]
  2. National Natural Science Foundation of China [82001944, 81725008, 81601502, 81671695, 81927801]
  3. China Postdoctoral Science Foundation [2019M661634, 2019TQ0231]
  4. Science and Technology Commission of Shanghai Municipality [19DZ2251100]
  5. Shanghai Municipal Health Commission [2019LJ21, SHSLCZDZK 03502]
  6. UNSW-CAS Collaborative Research Seed Program [GJHZ2072]

向作者/读者索取更多资源

The study introduces a scaffold engineering strategy that integrates highly active single-atomic iron catalysts into bioactive glass scaffold for effective osteosarcoma treatment and bacterial sterilization. The localized hyperthermia-reinforced nanocatalytic therapeutics offer efficient osteosarcoma ablation while preventing chronic osteomyelitis. This approach provides a clinically feasible strategy for overall osteosarcoma therapeutics, bacterial inhibition, and tissue regeneration.
Effective antitumor therapeutics with distinctive bactericidal and osteogenic properties are in high demand for comprehensive osteosarcoma treatment. Here, a scaffold engineering strategy that integrates highly active single-atomic iron catalysts (FeSAC) into a 3D printed bioactive glass (BG) scaffold is reported. Based on the atomically dispersed iron species within the catalysts, the engineered FeSAC displays prominent Fenton catalytic activity to generate toxic hydroxyl radicals (center dot OH) in response to the microenvironment specific to osteosarcoma. In addition, the constructed FeSAC-BG scaffold can serve as a sophisticated biomaterial platform for efficient osteosarcoma ablation, with concomitant bacterial sterilization via localized hyperthermia-reinforced nanocatalytic therapeutics. The destruction of the osteosarcoma, as well as the bacterial foci, can be achieved, further preventing susceptible chronic osteomyelitis during osteogenesis. In particular, the engineered FeSAC-BG scaffold is identified with advances in accelerated osteoconduction and osteoinduction, ultimately contributing to the sophisticated therapeutics and management of osteosarcoma. This work broadens the biomedical potential of single-atom catalysts and offers a comprehensive clinically feasible strategy for overall osteosarcoma therapeutics, bacterial inhibition, and tissue regeneration.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据